Strata Critical Medical, Inc.
About Strata Critical Medical, Inc.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $197.1M
- Net income
- $41.3M
- Total assets
- $325.5M
- Market cap
- $501.0M
- Gross margin
- 20.9%
- Operating margin
- -11.3%
- Net margin
- 21.0%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $197.1M
- Cost of revenue
- $156.0M
- Gross profit
- $41.1M
- Operating expenses
- $63.5M
- Operating income
- -$22.4M
- Income tax
- $432.0K
- Net income
- $41.3M
- EPS (basic)
- $0.50
- EPS (diluted)
- $0.50
Balance sheet
- Total assets
- $325.5M
- Current assets
- $126.2M
- Total liabilities
- $46.4M
- Current liabilities
- $19.8M
- Shareholders’ equity
- $279.1M
Cash flow
- Operating cash flow
- -$48.9M
- Investing cash flow
- $69.8M
- Financing cash flow
- -$8.9M
- Net cash flow
- $11.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $501.0M
- P/E ratio
- 11.7
- EPS (diluted)
- $0.5
- Shares outstanding
- 85.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 10, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $41.3M in FY2025.
- Gross margin of 20.9%, net margin 21.0%.
- Trading 9% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 11.7.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Strata Critical Medical, Inc..
Write a review
News about Strata Critical Medical, Inc.
News & sentiment via Polygon.io
